In one U. S. study, scientists found there were 31 percent fewercases of breast cancer among women who took Fosamax or other oralbisphosphonates than among women who didn't.
在美国的一项研究中，科学家发现，服用福善美或其他双磷酸盐口服药的女性，其乳腺癌患者数比没有服药的女性中乳腺癌患者数少31%。
In one U. S. study, scientists found there were 31 percent fewercases of breast cancer among women who took Fosamax or other oralbisphosphonates than among women who didn't.
在美国的一项研究中，科学家发现，服用福善美或其他双磷酸盐口服药的女性，其乳腺癌患者数比没有服药的女性中乳腺癌患者数少31%。
应用推荐